CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Increase in prevalence of urological disorders
3.4.1.2. Growing geriatric population
3.4.1.3. Rising number of kidney transplants
3.4.1.4. Technological advancements in stent design and composition material
3.4.2. Restraints
3.4.2.1. Complications associated with ureteral stent
3.4.2.2. Dearth of skilled professionals
3.4.3. Opportunities
3.4.3.1. Growing healthcare infrastructure and increase in healthcare investment in emerging nations
3.4.3.2. Development of innovative smart phone applications for ureteral stents
3.4.4. Impact analysis
CHAPTER 4 GLOBAL URETERAL STENTS MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. OPEN END STENTS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. CLOSED END STENTS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. DOUBLE PIGTAIL STENTS
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. MULTILOOP STENTS
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
CHAPTER 5 GLOBAL URETERAL STENTS MARKET, BY MATERIALS
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. METALLIC STENTS
5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast
5.3. POLYMER STENTS
5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Silicone Ureteral Stents
5.3.4.1. Market size and forecast
5.3.5. Hybrid Ureteral Stents
5.3.5.1. Market size and forecast
5.3.6. Polyurethane Ureteral Stents
5.3.6.1. Market size and forecast
CHAPTER 6 GLOBAL URETERAL STENTS MARKET, BY APPLICATION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. KIDNEY STONES
6.2.1. Market size and forecast
6.2.2. Ureteroscopy
6.2.2.1. Market size and forecast
6.2.3. Lithotripsy
6.2.3.1. Market size and forecast
6.2.4. Percutaneous Nephrolithotomy
6.2.4.1. Market size and forecast
6.3. KIDNEY TRANSPLANTATION
6.3.1. Market size and forecast
6.4. TUMORS
6.4.1. Market size and forecast
6.5. URINARY INCONTINENCE
6.5.1. Market size and forecast
6.6. OTHER APPLICATIONS
6.6.1. Market size and forecast
CHAPTER 7 GLOBAL URETERAL STENTS MARKET, BY END USER
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. HOSPITALS
7.2.1. Market size and forecast
7.3. CLINICS
7.3.1. Market size and forecast
7.4. AMBULATORY SURGICAL CENTERS (ASCS)
7.4.1. Market size and forecast
CHAPTER 8 GLOBAL URETERAL STENTS MARKET, BY REGION
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.4. U.S.
8.2.5. Canada
8.2.6. Mexico
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.4. GERMANY
8.3.5. UK
8.3.6. FRANCE
8.3.7. SPAIN
8.3.8. ITALY
8.3.9. REST OF EUROPE
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.4. JAPAN
8.4.5. CHINA
8.4.6. INDIA
8.4.7. SOUTH KOREA
8.4.8. REST OF ASIA-PACIFIC
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.4. BRAZIL
8.5.5. SOUTH AFRICA
8.5.6. SAUDI ARABIA
8.5.7. REST OF LAMEA
CHAPTER 9 COMPANY PROFILES
9.1. BOSTON SCIENTIFIC CORPORATION
9.1.1. Company overview
9.1.2. Operating business segments
9.1.3. Business performance
9.1.4. Key strategic moves and developments
9.2. B. BRAUN HOLDING GMBH & CO. KG
9.2.1. Company overview
9.2.2. Operating business segments
9.2.3. Business performance
9.2.4. Key strategic moves and developments
9.3. COOK GROUP INCORPORATED
9.3.1. Company overview
9.3.2. Operating business segments
9.3.3. Business performance
9.3.4. Key strategic moves and developments
9.4. C. R. BARD, INC.
9.4.1. Company overview
9.4.2. Operating business segments
9.4.3. Business performance
9.4.4. Key strategic moves and developments
9.5. COLOPLAST LTD.
9.5.1. Company overview
9.5.2. Operating business segments
9.5.3. Business performance
9.5.4. Key strategic moves and developments
9.6. MEDLINE INDUSTRIES, INC.
9.6.1. Company overview
9.6.2. Operating business segments
9.6.3. Business performance
9.6.4. Key strategic moves and developments
9.7. ALLIUM MEDICAL SOLUTIONS LTD.
9.7.1. Company overview
9.7.2. Operating business segments
9.7.3. Business performance
9.7.4. Key strategic moves and developments
9.8. PNN MEDICAL A/S
9.8.1. Company overview
9.8.2. Operating business segments
9.8.3. Business performance
9.8.4. Key strategic moves and developments
9.9. TELEFLEX INCORPORATED
9.9.1. Company overview
9.9.2. Operating business segments
9.9.3. Business performance
9.9.4. Key strategic moves and developments
9.10. OLYMPUS CORPORATION
9.10.1. Company overview
9.10.2. Operating business segments
9.10.3. Business performance
9.10.4. Key strategic moves and developments